Linagliptin Pharma Grade
38 Inquiries
668270-12-0
Pharmaceutical Grade
QINGDAO
25kg/10kg Drum
2017-02-02
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceLinagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM.
Linagliptin is a xanthine that is 7H-xanthine bearing (4-methylquinazolin-2-yl)methyl, methyl, but-2-yn-1-yl and 3-aminopiperidin-1-yl substituents at positions 1, 3, 7 and 8 respectively (the R-enantiomer). Used for treatment of type II diabetes. It has a role as an EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor and a hypoglycemic agent. It is a member of quinazolines and an aminopiperidine. It derives from a 7H-xanthine.|Linagliptin is a DPP-4 inhibitor developed by Boehringer Ingelheim for the treatment of type II diabetes. Linagliptin differs from other DPP-4 inhibitors in that it has a non-linear pharmacokinetic profile, is not primarily eliminated by the renal system, and obeys concentration dependant protein binding. Linagliptin was approved by the FDA on May 2, 2011.|Linagliptin is a Dipeptidyl Peptidase 4 Inhibitor. The mechanism of action of linagliptin is as a Dipeptidyl Peptidase 4 Inhibitor.|Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other oral hypoglycemic agents. Linagliptin has been linked to rare instances of clinically apparent liver injury.|Linagliptin is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. The inhibition of DPP-4 by linagliptin appears to be longer lasting than that by some other DPP-4 inhibitors tested.|A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.Basic Info-
Product Name:
Linagliptin
Other Name:1H-Purine-2,6-dione,8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-;1H-Purine-2,6-dione,8-[(3R)-3-amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;BI 1356;ONDERO;Linagliptin;BI 1356BS;Tradjenta;Trazenta;(R)-8-[3-Aminopiperidin-1-yl]-7-(2-butynyl)-3-methyl-1-(4-methylquinazolin-2-ylmethyl)xanthine;Trajenta
CAS No.:668270-12-0
Molecular Formula:C25H28N8O2
InChIKeys:InChIKey=LTXREWYXXSTFRX-QGZVFWFLSA-N
Molecular Weight:472.54
Exact Mass:472.54
UNII:3X29ZEJ4R2
NCI Thesaurus Code:C83887
Color/Form:White to yellow solid; also reported as a crystalline solid
ATC Code:A10BD11|A10BH05|A10BD19|A - Alimentary tract and metabolism
HScode:29335990
Categories:
Characteristics-
PSA:
114
XLogP3:1.9
Density:1.39
Melting Point:202 °C
Boiling Point:661.2°C at 760 mmHg
Flash Point:353.7±34.3 °C
Refractive Index:1.717
Water Solubility:H2O: <1 mg/mL;soluble in methanol; sparingly soluble in ethanol; very slightly soluble in isopropanol, alcohol
Vapor Pressure:5.75X10-17 mm Hg at 25 deg C (est)
Dissociation Constants:pKa1 = 1.9; pKa2 = 8.6
Experimental Properties:Slightly hygroscopic
Hazard IdentificationClassification of the substance or mixture
Skin irritation, Category 2
Eye irritation, Category 2
Specific target organ toxicity â single exposure, Category 3
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Warning
Hazard statement(s) H315 Causes skin irritation
H319 Causes serious eye irritation
H335 May cause respiratory irritation
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P321 Specific treatment (see ... on this label).
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P319 Get medical help if you feel unwell.
Storage P403+P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Location:
Tianyuan Development zones, Deyang, Sichuan
SiChuan Tongsheng Biopharmaceutical CO., LTD established at 2011, located in development zone in Deyang with comfortable weather and pleasant view connected with high way directly to Chengdu,70 KM to Shuangliu airport.We mainly focus on the research of intermediates towards to Cardiovascular Drugs, anti-cancer drugs, Hepatitis C drug include Vildagliptin, linagliptin, Alogliptin, sitagliptin, sofosbuvir, Ledipasvir etc,The company has the complete set of R&D Center leading by 3 Doctors with 31 Lab stuff and equipments of different test scale.Our research group owns the best chemical, medicine filed background and abundant experience of management and technics. For now, a range of cooperations have been built with the unit like Chinese Academy of Science and so on, For sure, we will provide the comprehensive and efficient chemical customized service to our clients.The total area of the plant covers over 21000 m2 which includes the refining-drying-packing workshop about 2100 m2 and synthetise workshop about 2600 m2. The yearly production cabability can reach over 1000 MT and we are hanling the skills like nitrogen protection, reaction within -78~240℃, reaction within 5~12 Mpa maturely. We have followed the every GMP requirment to design and build the facility and producing line. It is our purpose to grow up to a contributive APIs enterprise within 3 year and realising the amount of sales over 100 millions.Along with the complete management system and quality control team,technics research group, satisfactory selling and after-sales service allowus to be confident to our procuction and expangding. We regard thehonesty and quality as the source of life, so we want to share the ideasof “symbiosis , common prosperity and win-win”with all of you whowould like to be a part in the future of medical chemistry.
-
-
Inquiry History38 Inquiries
Country Product Purchase Quantity Date Posted
India
Linagliptin
10.00 KG Nov 9, 2023
India
Linagliptin API
500.00 KG Sep 11, 2025
India
Linagliptin
50.00 KG Nov 23, 2023
India
Linagliptin
5.00 KG Jan 22, 2024
India
Linagliptin
1.00 KG Mar 6, 2024
India
Linagliptin
1.00 KG Jan 19, 2024
India
Linagliptin
10.00 MT Nov 24, 2023
India
Linagliptin
50.00 KG Nov 20, 2023
Belgium
Linagliptin API
200.00 KG Jun 5, 2025
India
Linagliptin
100.00 KG Nov 20, 2023
India
Linagliptin
10.00 KG Dec 12, 2023
India
Linagliptin Microized
5 KG Jul 9, 2025
India
Linagliptin
25 KG Feb 13, 2026
India
Linagliptin
5 G Nov 25, 2025
India
LINGLIPTIN
25.00 KG Mar 25, 2025
India
Linagliptin
50.00 KG Mar 6, 2025
India
Linagliptin
25.00 KG Jan 6, 2025
United Arab Emirates
Linagliptin
2 KG Jul 15, 2026
India
Linagliptin Intermediate
10.00 KG Jul 29, 2025
Bangladesh
Linagliptin
1 MT Jul 15, 2024 Post an enquiry for this product